Small Animal Irradiator with Cone Beam CT

带锥形束 CT 的小动物照射器

• 批准号: 8051205
• 负责人: ROSS B MIKKELSEN
• 金额: $ 59.92万
• 依托单位: VIRGINIA COMMONWEALTH UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-03-07 至 2012-03-06
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8051205
• 关键词: Animals; Biochemistry; Cancer Center; Cell Proliferation; Clinic; Clinical; Colon; Colon Carcinoma; Cyclotrons; Dose; Exposure to; Funding; Goals; Heart; Hour; Human Genetics; Hypersensitivity; Hypoxia; Image; Immunotherapy; Investigation; Kidney; Laboratory Study; Linear Accelerator Radiotherapy Systems; Lung; Malignant neoplasm of prostate; Normal tissue morphology; Organ; Pharmacology and Toxicology; Positron-Emission Tomography; Property; Protocols documentation; Radiation; Radiation Oncology; Radiation therapy; Request for Proposals; Research; Research Personnel; Scientist; Security; Testing; Tomography, Computed, Scanners; Transgenic Mice; Translating; Translations; Treatment Protocols; Tumor Tissue; United States National Institutes of Health; Universities; Virginia; chemotherapy; cone-beam computed tomography; cost; design; image registration; in vivo; irradiation; malignant breast neoplasm; molecular imaging; neoplastic cell; neurosurgery; patient safety; radiation effect; response

DESCRIPTION (provided by applicant): This proposal requests funds for the purchase of a state of the art small animal radiation research platform (SARRP) irradiator. SARRP is first of its kind that is commercially available and that combines cone beam computed tomography (CT) imaging with micro-irradiation enabling basic scientists and translational researchers to utilize the conformal, fractionated radiotherapy protocols that are currently used in the clinic in studies with small animals. This is essential for translating laboratory studies that combine radiotherapy with chemo- or immunotherapies. Studies on the normal tissue effects of radiation also require highly conformal radiation treatments. The goal in many cases is to limit radiation exposure to one organ (e.g. the heart) or part of an organ (e.g. one lung or one kidney) to facilitate analysis of normal tissue damage without confounding effects of other normal tissue damage or using unrealistically high single radiation doses. Presently at Virginia Commonwealth University there is a Cs137 irradiator, a retired clinical Co60 unit and the clinical linear accelerators (linasc). The Co60 unit is being decommissioned because of cost and security issues. The Cs137 irradiator does not provide conformal dose distributions. The linacs in their clinical configurations do not have the conformal properties of the SARRP that are optimal for small animal studies. In addition, they can be only operated after clinic hours and there are always the concerns of patient safety (e.g allergies). The SARRP will be installed in the Massey Cancer Center vivarium minimizing transport of valuable transgenic mice outside the "clean" vivarium. The major users are NIH funded and come from the Departments of Radiation Oncology, Human Genetics, Biochemistry, Neurosurgery and Pharmacology/Toxicology. Their studies range from studies with breast, prostate and colon cancers to studies of normal tissue responses including colon, lung, and heart and combine radiotherapy with either chemotherapeutics or immunotherapy. One investigator has on-going studies on PET (Positron Emission Tomography) using a PET/CT scanner designed for small animal studies in the Molecular Imaging Facility at Virginia Commonwealth University. With appropriate image registration which the SARRP can accommodate, PET imaging for hypoxia or tumor cell proliferation with probes synthesized in the cyclotron at Virginia Commonwealth University can be used to develop biologically guided radiotherapy protocols using SARRP. For all investigations the ability to deliver precise conformal radiation to either tumor or normal tissue is essential for testing mechanistic hypotheses in vivo and their translation into testable treatment protocols.

描述（由申请人提供）：本提案要求为购买最先进的小动物辐射研究平台（SARRP）辐照器提供资金。SARRP是第一种商业化的，它将锥形束计算机断层扫描（CT）成像与微辐射相结合，使基础科学家和翻译研究人员能够利用目前在临床上用于小动物研究的适形分次放射治疗方案。这对于将联合收割机与化疗或免疫疗法相结合的实验室研究的翻译至关重要。对辐射的正常组织效应的研究也需要高度适形的辐射治疗。在许多情况下，目标是限制对一个器官（例如心脏）或器官的一部分（例如一个肺或一个肾）的辐射暴露，以便于分析正常组织损伤，而不会混淆其他正常组织损伤的影响或使用不切实际的高单次辐射剂量。 目前在弗吉尼亚联邦大学有一个Cs 137辐照器，一个退休的临床Co 60单位和临床直线加速器（linasc）。由于成本和安全问题，Co 60装置正在退役。Cs 137辐照器不提供适形剂量分布。在临床配置中的直线加速器不具有SARRP的适形特性，而适形特性对于小动物研究是最佳的。此外，它们只能在门诊时间后操作，并且始终存在患者安全问题（例如过敏）。SARRP将被安装在梅西癌症中心的动物园中，最大限度地减少有价值的转基因小鼠在“干净”动物园外的运输。 主要用户由NIH资助，来自放射肿瘤学、人类遗传学、生物化学、神经外科和药理学/毒理学等部门。他们的研究范围从乳腺癌、前列腺癌和结肠癌的研究到包括结肠、肺和心脏在内的正常组织反应的研究，并将联合收割机与化疗或免疫疗法相结合。一位研究者正在弗吉尼亚联邦大学的分子成像设施中使用专为小动物研究设计的PET/CT扫描仪进行PET（正电子发射断层扫描）研究。通过SARRP可以适应的适当图像配准，使用弗吉尼亚联邦大学回旋加速器中合成的探针进行缺氧或肿瘤细胞增殖的PET成像可用于使用SARRP开发生物引导的放射治疗方案。对于所有的调查，提供精确的适形辐射的能力，无论是肿瘤或正常组织是必不可少的测试机制的假设在体内和他们的翻译成可测试的治疗方案。